These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 25728990

  • 1. The interplay of effector and regulatory T cells in cancer.
    Roychoudhuri R, Eil RL, Restifo NP.
    Curr Opin Immunol; 2015 Apr; 33():101-11. PubMed ID: 25728990
    [Abstract] [Full Text] [Related]

  • 2. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.
    Baeyens A, Saadoun D, Billiard F, Rouers A, Grégoire S, Zaragoza B, Grinberg-Bleyer Y, Marodon G, Piaggio E, Salomon BL.
    J Immunol; 2015 Feb 01; 194(3):999-1010. PubMed ID: 25548233
    [Abstract] [Full Text] [Related]

  • 3. Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.
    Khan S, Burt DJ, Ralph C, Thistlethwaite FC, Hawkins RE, Elkord E.
    Clin Immunol; 2011 Jan 01; 138(1):85-96. PubMed ID: 21056008
    [Abstract] [Full Text] [Related]

  • 4. Regulatory circuits of T cell function in cancer.
    Speiser DE, Ho PC, Verdeil G.
    Nat Rev Immunol; 2016 Oct 01; 16(10):599-611. PubMed ID: 27526640
    [Abstract] [Full Text] [Related]

  • 5. Regulatory T cells form stable and long-lasting cell cluster with myeloid dendritic cells (DC).
    Herman S, Krenbek D, Klimas M, Bonelli M, Steiner CW, Pietschmann P, Smolen JS, Scheinecker C.
    Int Immunol; 2012 Jul 01; 24(7):417-26. PubMed ID: 22366044
    [Abstract] [Full Text] [Related]

  • 6. Regulatory T cells: how do they suppress immune responses?
    Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T.
    Int Immunol; 2009 Oct 01; 21(10):1105-11. PubMed ID: 19737784
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Polyclonal Treg cells modulate T effector cell trafficking.
    Davidson TS, Shevach EM.
    Eur J Immunol; 2011 Oct 01; 41(10):2862-70. PubMed ID: 21728170
    [Abstract] [Full Text] [Related]

  • 12. Expanding and converting regulatory T cells: a horizon for immunotherapy.
    Khattar M, Chen W, Stepkowski SM.
    Arch Immunol Ther Exp (Warsz); 2009 Oct 01; 57(3):199-204. PubMed ID: 19479206
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).
    Czystowska M, Strauss L, Bergmann C, Szajnik M, Rabinowich H, Whiteside TL.
    J Mol Med (Berl); 2010 Jun 01; 88(6):577-88. PubMed ID: 20225066
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antileukemic T-cell responses can be predicted by the composition of specific regulatory T-cell subpopulations.
    Schick J, Vogt V, Zerwes M, Kroell T, Kraemer D, Köhne CH, Hausmann A, Buhmann R, Tischer J, Schmetzer H.
    J Immunother; 2013 May 01; 36(4):223-37. PubMed ID: 23603857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.